Company / Income Tax
UroGen Pharma Ltd. Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$78.0K
FY2025
5-year range
$78.0K / $3.9M
FY2021-FY2025
Trend
-98.0%
vs FY2024
Sector context
#104 of 204
Health Care
What the data says
At $78,000, UroGen Pharma Ltd.'s income tax ranks #101 of 204 in the Health Care sector. Income Tax has fluctuated over the past 9 years, ranging from $19,000 in FY2019 to $4M in FY2024.
Based on SEC 10-K filings.
$78,000 in FY2025 with a 5-year CAGR of -52.9%.
Improved from $2M to $78,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -62.2%
- 5-Year CAGR
- -52.9%
- 10-Year CAGR
- -
Sector benchmark
#101 of 204 in Health CareTop 49% of 204This company $78.0K Sector average $118.7M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -52.9%, indicating a declining trend.
- In FY2025, income tax decreased 98.0% year-over-year.
- Ranks #104 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $78.0K | -98.0% |
| FY2024 | $3.9M | +123.4% |
| FY2023 | $1.8M | +21.1% |
| FY2022 | $1.4M | +0.0% |
| FY2021 | $1.4M | -57.1% |
| FY2020 | $3.4M | +17657.9% |
| FY2019 | $19.0K | -84.8% |
| FY2018 | $125.0K | +557.9% |
| FY2017 | $19.0K | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026